Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression.

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression.
复制标题

通过 microRNA-200/ZEB1 轴控制肿瘤细胞 PD-L1 表达和瘤内免疫抑制来调节转移。

DOI:
10.1038/ncomms6241
复制
发表时间:
2014-10-28
影响因子:
16.6
通讯作者:
Qin, F. Xiao-Feng
Qin, F. Xiao-Feng
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Chen, Limo;Gibbons, Don L.;Goswami, Sangeeta;Cortez, Maria Angelica;Ahn, Young-Ho;Byers, Lauren A.;Zhang, Xuejun;Yi, Xiaohui;Dwyer, David;Lin, Wei;Diao, Lixia;Wang, Jing;Roybal, Jonathon D.;Patel, Mayuri;Ungewiss, Christin;Peng, David;Antonia, Scott;Mediavilla-Varela, Melanie;Robertson, Gordon;Jones, Steve;Suraokar, Milind;Welsh, James W.;Erez, Baruch;Wistuba, Ignacio I.;Chen, Lieping;Peng, Di;Wang, Shanshan;Ullrich, Stephen E.;Heymach, John V.;Kurie, Jonathan M.;Qin, F. Xiao-Feng

文献摘要

参考文献

被引文献

相似文献

肿瘤浸润淋巴细胞(TIL)的免疫抑制是晚期癌症的共同特征,但其生物学基础尚不清楚。我们在这里证明了上皮到间质转化(EMT)和CD8+ TIL免疫抑制之间的分子联系,这是癌症进展的两个关键驱动因素。我们发现microRNA-200 (miR-200),一种EMT和转移的细胞自主抑制因子,靶向PD-L1。此外,作为EMT激活剂和miR-200的转录抑制因子,ZEB1可以缓解miR-200对肿瘤细胞PD-L1的抑制,从而导致CD8+ T细胞的免疫抑制和转移。这些发现得到了多个人类肺癌数据集中EMT评分、miR-200水平和PD-L1表达之间的强大相关性的支持。除了揭示EMT和T细胞功能障碍之间的联系外,这些发现还表明ZEB1通过迄今为止未被发现的细胞非自主机制促进转移,并表明由EMT激活剂驱动恶性进展的患者亚组可能对PD-L1拮抗剂治疗有反应。
Immunosuppression of tumor-infiltrating lymphocytes (TIL) is a common feature of advanced cancer, but its biological basis has remained obscure. We demonstrate here a molecular link between epithelial-to-mesenchymal transition (EMT) and CD8+ TIL immunosuppression, two key drivers of cancer progression. We show that microRNA-200 (miR-200), a cell-autonomous suppressor of EMT and metastasis, targets PD-L1. Moreover, ZEB1, an EMT activator and transcriptional repressor of miR-200, relieves miR-200 repression of PD-L1 on tumor cells, leading to CD8+ T cell immunosuppression and metastasis. These findings are supported by robust correlations between the EMT score, miR-200 levels and PD-L1 expression in multiple human lung cancer datasets. In addition to revealing a link between EMT and T cell dysfunction, these findings also show that ZEB1 promotes metastasis through a heretofore unappreciated cell non-autonomous mechanism, and suggest that subgroups of patients in whom malignant progression is driven by EMT activators may respond to treatment with PD-L1 antagonists.
DOI: 10.1371/journal.pone.0012445
发表时间: 2010-08-27
期刊: PloS one
影响因子: 3.7
作者:
Kong D;Banerjee S;Ahmad A;Li Y;Wang Z;Sethi S;Sarkar FH
通讯作者: Sarkar FH
T细胞共刺激和共抑制的分子机制。
DOI: 10.1038/nri3405
发表时间: 2013-04
期刊: Nature reviews. Immunology
影响因子: --
作者:
通讯作者: --
通过PD-1-PD-1配体阻滞来振兴耗尽的HIV特异性T细胞。
DOI: 10.1084/jem.20061800
发表时间: 2006-10-02
影响因子: 15.3
作者:
Freeman, Gordon J.;Wherry, E. John;Ahmed, Rafi;Sharpe, Arlene H.
通讯作者: Sharpe, Arlene H.
DOI: 10.1016/j.ccr.2012.02.022
发表时间: 2012-03-20
期刊: CANCER CELL
影响因子: 50.3
作者:
Hanahan, Douglas;Coussens, Lisa M.
通讯作者: Coussens, Lisa M.
DOI: 10.1016/1074-7613(94)90087-6
发表时间: 1994-09-01
期刊: IMMUNITY
影响因子: 32.4
作者:
DIGHE, AS;RICHARDS, E;SCHREIBER, RD
通讯作者: SCHREIBER, RD